PODCAST · health
Zepbound Explained — The New Weight Loss Drug
by Inception Point Ai
Eli Lilly's Zepbound delivers up to 21% weight loss through a groundbreaking dual-hormone mechanism that's reshaping obesity treatment. Join host Julia Cartwright as she decodes the science, clinical trial results, and real-world access barriers behind this revolutionary injection. Each episode stands alone, exploring a different facet of medicine's newest metabolic game-changer. For more content like this, visit QuietPlease.aiThis show includes AI-generated content.
-
4
Zepbound Explained — Navigate the new frontier of weight loss with Julia Cartwright
Join host Julia Cartwright as she breaks down Zepbound, the groundbreaking weight loss drug revolutionizing obesity treatment with its dual-hormone approach. Discover how this weekly injection works, who qualifies, and what clinical trials reveal—explained in plain English. Get the straight facts to make informed decisions about this weight management breakthrough. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
-
3
Zepbound Explained — The New Weight Loss Drug - The Numbers Don't Lie
Join AI host Julia Cartwright as she breaks down the groundbreaking SURMOUNT clinical trials for tirzepatide (Zepbound). We cover the landmark data showing average weight loss of 21% at the highest dose, with 57% of participants losing over 20% of body weight—results previously seen only with bariatric surgery, fundamentally reshaping obesity medicine's possibilities. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
-
2
Zepbound Explained — The New Weight Loss Drug - Who Gets the Shot? Eligibility & Access
Julia Cartwright explores who qualifies for Zepbound, the GLP-1 weight loss medication showing 15-21% body weight reduction in trials. Learn FDA eligibility criteria, BMI thresholds, required comorbidities, and how to navigate the complex insurance prior authorization process that stands between patients and this transformative treatment option. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
-
1
Zepbound Explained — The New Weight Loss Drug - The Twincretin: One Shot, Two Hormones
Julia Cartwright breaks down the science behind Zepbound (tirzepatide), the FDA-approved weight loss drug that targets two gut hormones simultaneously. Learn how this once-weekly injection helped clinical trial participants lose up to 21% of their body weight by suppressing appetite, delaying digestion, and regulating metabolism—without gimmicks, just biochemistry. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Eli Lilly's Zepbound delivers up to 21% weight loss through a groundbreaking dual-hormone mechanism that's reshaping obesity treatment. Join host Julia Cartwright as she decodes the science, clinical trial results, and real-world access barriers behind this revolutionary injection. Each episode stands alone, exploring a different facet of medicine's newest metabolic game-changer. For more content like this, visit QuietPlease.aiThis show includes AI-generated content.
HOSTED BY
Inception Point Ai
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Zepbound Explained — The New Weight Loss Drug have?
Zepbound Explained — The New Weight Loss Drug currently has 4 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Zepbound Explained — The New Weight Loss Drug about?
Eli Lilly's Zepbound delivers up to 21% weight loss through a groundbreaking dual-hormone mechanism that's reshaping obesity treatment. Join host Julia Cartwright as she decodes the science, clinical trial results, and real-world access barriers behind this revolutionary injection. Each episode...
How often does Zepbound Explained — The New Weight Loss Drug release new episodes?
Zepbound Explained — The New Weight Loss Drug has 4 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Zepbound Explained — The New Weight Loss Drug?
You can listen to Zepbound Explained — The New Weight Loss Drug on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Zepbound Explained — The New Weight Loss Drug?
Zepbound Explained — The New Weight Loss Drug is created and hosted by Inception Point Ai.
URL copied to clipboard!